Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know
06:56pm, Wednesday, 17'th Mar 2021
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $131.10, marking a +0.41% move from the previous day.
Is CRISPR Therapeutics Stock Poised to Soar Nearly 30%?
07:03am, Wednesday, 17'th Mar 2021
It's a firm maybe.
CRISPR Therapeutics Stock Looks Like a Long-Term Biotech Winner
02:36pm, Tuesday, 16'th Mar 2021
Gene editing has the potential to revolutionize medicine. With CRISPR Therapeutics leading the way, CRSP stock should benefit.
CRISPR Therapeutics AG's (CRSP) CEO Samarth Kulkarni Presents At 33rd Annual ROTH Conference (Transcript)
03:12pm, Monday, 15'th Mar 2021
CRISPR Therapeutics AG's (CRSP) CEO Samarth Kulkarni Presents At 33rd Annual ROTH Conference (Transcript)
2 Stocks Cathie Wood Loves That Should Be Bigger Winners Than Tesla
06:04am, Friday, 12'th Mar 2021
Tesla's great, but these Cathie Wood favorites have even better growth prospects.
CRISPR Therapeutics Is a Falling Knife You Don't Want to Catch
04:52pm, Thursday, 11'th Mar 2021
With possibly the worst of the novel coronavirus pandemic over, on the surface CRSP stock seems to be a worthwhile rebound pick. However, the technical outlook suggests otherwise.
CRISPR Therapeutics Announces Poster Presentation at the American Association for Cancer Research 2021 Annual Meeting
05:03pm, Wednesday, 10'th Mar 2021
ZUG, Switzerland and CAMBRIDGE, Mass., March 10, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for se
Gene Editing Stocks: What BLUE, NTLA, BEAM, CRSP and EDIT Are Doing Today
01:26pm, Wednesday, 10'th Mar 2021
Gene editing stocks are on the move Wednesday with investors taking extra interest in biotech companies on news from two major players. The post Gene Editing Stocks: What BLUE, NTLA, BEAM, CRSP and ED
Crispr Therapeutics AG's (CRSP) CEO Samarth Kulkarni Presents at Barclays Global Healthcare Conference 2017 (Transcript)
02:35pm, Tuesday, 09'th Mar 2021
Crispr Therapeutics AG's (CRSP) CEO Samarth Kulkarni Presents at Barclays Global Healthcare Conference 2017 (Transcript)
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know
06:59pm, Friday, 05'th Mar 2021
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $114.65, marking a -0.73% move from the previous day.
Bulls & Bears Battle It Out In Big Tech
04:42pm, Thursday, 04'th Mar 2021
Yields are on the rise and valuation-propelled tech is getting deflated.
Anthem, BioMarin, CRISPR, GE and More Thursday Afternoon Analyst Calls
12:25pm, Thursday, 04'th Mar 2021
With the trading day about halfway over, the broad markets had managed to push higher on the day, despite dipping into the red earlier.
Why It's Time to Go All-In on These 3 Revolutionary Stocks
06:30am, Wednesday, 03'rd Mar 2021
The companies with game-changing technology are often the best growth picks.
The Buzzing Gene-Editing Market Of Crispr Therapeutics
08:54pm, Monday, 01'st Mar 2021
The Buzzing Gene-Editing Market Of Crispr Therapeutics
CRISPR Therapeutics: Roadblock Ahead
03:53pm, Tuesday, 23'rd Feb 2021
CRISPR Therapeutics: Roadblock Ahead
